Due to the radiosensitivity of the lung, toxic endpoints, in the form of radiation pneumonitis
and pulmonary fibrosis, are relatively frequent outcomes following radiation treatment of …

Pulmonary injury is more common in patients undergoing radiation therapy for lungs and
other thoracic malignancies. Recently with the use of most-advanced technologies powerful …

The goal of radiation therapy is to reduce or eliminate tumor burden while sparing normal
tissues from long-term injury. Thoracic radiation presents a unique challenge because of the …

Thoracic malignancies are often a difficult group of tumors to treat definitively as the
radiation doses needed to achieve a high probability for tumor control are often associated …

Chemo-radiotherapy and systemic therapies have proven satisfactory outcomes as standard
treatments for various thoracic malignancies; however, adverse pulmonary effects, like …

Toxicity concerns from thoracic radiation therapy in the treatment of lung cancers have
changed substantially over the past few decades. Survival in the treatment of lung cancer …

Radiation therapy (RT) for thoracic-region tumors often causes lung injury. The incidence of
lung toxicity depends on the method of assessment (eg, radiographs, patient's symptoms, or …

Radiation-induced lung injury (RILI) remains a major obstacle for thoracic radiotherapy for
the treatment of lung cancer, esophageal cancer and lymphoma. It is the principal dose …

Since 9/11, there have been concerns that terrorists may detonate a radiological or nuclear
device in an American city. Aside from several decorporation and blocking agents for use …

Radiation-induced normal tissue reactions of the lung, ie pneumonitis or fibrosis, are
common side effects occurring approximately 6–12 weeks and 1–2 years after completion of …